REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Richfield (India) Pharmaceuiticals Private Limited (India)

Main Activities: Health Care and Social Assistance
Full name: Richfield (India) Pharmaceuiticals Private Limited Profile Updated: January 13, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Richfield (india) Pharmaceuiticals Private Limited is an unlisted company, incorporated on 12/12/2005. It has its registered office in the State of Karnataka, India. Company's corporate identification number (CIN) is U85110KA2005PTC037914 and registration number is 037914. The company is a trade company, it is engaged in wholesale trading.

Legal Address
No.102, Cts No. 420/3A, First Floor Enkay Complex, Keshwapur
Dharwad; Karnataka; Postal Code: 580023

Contact Details: Purchase the Richfield (India) Pharmaceuiticals Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Richfield (India) Pharmaceuiticals Private Limited report to view the information.
Financial Auditors:
Purchase the Richfield (India) Pharmaceuiticals Private Limited report to view the information.
Incorporation Date:
December 12, 2005
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Whole Time Director
Purchase this report to view the information.
Managing Director
Company Performance
Financial values in the chart are available after Richfield (India) Pharmaceuiticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
8.58%▲
Total operating revenue
8.32%▲
Operating profit (EBIT)
31.25%▲
EBITDA
30.36%▲
Net Profit (Loss) for the Period
47.62%▲
Total Assets
-4.56%▼
Total Equity
36.05%▲
Operating Profit Margin (ROS)
1.37%▲
Net Profit Margin
1.39%▲
Return on Equity (ROE)
2.05%▲
Debt/Equity
-56.03%▼
Quick Ratio
1.04%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo